Vanguard Global Advisers
XGN icon

Vanguard Global Advisers’s Exagen XGN Stock Holding History

Vanguard Global Advisers’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Hold
4,141
– – ﹤0.01% 3339
2026
Q1 		$12.4K Buy
+4,141
New +$16K ﹤0.01% 3442

Other funds holding XGN

NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Vanguard Global Advisers's XGN Position: Q2 2026 in Review

Vanguard Global Advisers held its Exagen (XGN) position steady in Q2 2026 at 4,141 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3339.

Vanguard Global Advisers first reported a position in XGN in Q1 2026 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Vanguard Global Advisers held 4,141 shares of Exagen worth $19.3K as of Q2 2026.
  • Vanguard Global Advisers left its Exagen share count unchanged in Q2 2026.
  • Exagen made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3339 holding.
  • Vanguard Global Advisers first reported a position in Exagen in Q1 2026 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.